Menu
Home
Log in / Register
 
Home arrow Philosophy arrow Philosophical Issues in Pharmaceutics: Development, Dispensing, and Use
Source

References

Access to Medicine Index. 2014. Licensing Medicines for HIV/AIDS: Critical Mechanism for Ending the Epidemic. http://www.accesstomedicineindex.org/licensing-medicines-hivaids- critical-mechanism-ending-epidemic. Accessed 18 Feb 2015.

Angell, M. 2004. The Truth About the Drug Companies: How They Deceive Us and What to Do About It. New York: Random House.

Badcott, D. 2013. Big Pharma: A Former Insider’s View. Medicine, Health Care and Philosophy 16: 249-264.

Bill & Melinda Gates Foundation. 2015. www.gatesfoundation.org. Accessed 18 Feb 2015.

Chang, P.L. 2006. Who’s in the Business of Saving Lives? The Journal of Medicine and Philosophy 31(5): 465-482.

Clinton Health Access Initiative. Dec 2014. ARV Market Report: The State of the Antiretroviral Drug Market in Low- and Middle-income Countries. Boston: USA.

Cohen, M.S., et al. 2011. Prevention of HIV-1 Infection with Early Antiretroviral Therapy. The New England Journal of Medicine 365(5): 493-505.

De George, R.T. 2005a. Intellectual Property and Pharmaceutical Drugs: An Ethical Analysis. Business Ethics Quarterly 15(4): 549-575.

--. 2005b. Business Ethics. 6th ed. Upper Saddle River: Prentice Hall.

Donovan, G. 2014. Ebola, Epidemics, and Ethics—What We Have Learned. Philosophy, Ethics, and Humanities in Medicine 9: 15.

Finegold, D., and A. Moser. 2006. Ethical Decision-making in Bioscience Firms. Nature Biotechnology 24(3): 285-290.

Goodin, R. 1985. Protecting the Vulnerable: A Reanalysis of Our Social Responsibilities. Chicago: University of Chicago Press.

Gruskin, S., and Z. Raad. 2010. Are Drug Companies Living Up to Their Human Rights Responsibilities? Moving Toward Assessment. PLoS Medicine 7(9): 1-3.

Hanson, K., et al. 2003. Expanding Access to Priority Health Interventions: A Framework for Understanding the Constraints to Scaling-Up. Journal of International Development 15: 1-14.

Ho, A. 2005. Pharmaceutical Corporations and the Duty to Aid in HIV/AIDS Epidemic. Business & Professional Ethics Journal 24(4): 51-81.

Holm, S. 2000. Three Reasons Why a Global Market in Pharmaceutical Products Is Inherently Unjust. Journal of Social Philosophy 31: 398.

Huebner, J.M. 2014. Moral Psychology and the Intuition that Pharmaceutical Companies Have a ‘Special’ Obligation to Society. Journal of Business Ethics 122: 501-510.

Jackson, K. 1993. Global Distributive Justice and the Corporate Duty to Aid. Journal of Business Ethics 12: 549.

Joffe, S. 2014. Evaluating Novel Therapies During the Ebola Epidemic. Journal of the American Medical Association 312(13): 1299-1300.

Kelly, M. 2001. Property Privileges (Not Rights): The Cipro case reminds us that property rights are subordinate to the public good. Business Ethics 15(6, Nov/Dec): 4.

Kroll, D. 2014. Ebola ‘Secret Serum’: Small Biopharma, The Army and Big Tobacco. Forbes. http://www.forbes.com/sites/davidkroll/2014/08/05/ebola-secret-serum-small-biopharma-the- army-and-big-tobacco/. Accessed 23 Feb 2015.

Leisinger, K.M. 2005. The Corporate Social Responsibility of the Pharmaceutical Industry: Idealism Without Illusion and Realism Without Resignation. Business Ethics Quarterly 15(4): 577-594.

Leventer, H. 2002. It Is Not Unethical, Though It Is Often Unwise, to Override Patents. The American Journal of Bioethics 2: 50.

McGraw, A.P., J.A. Schwartz, and P.E. Tetlock. 2011. From the Commercial to the Communal: Reframing Taboo Trade-offs in Religious and Pharmaceutical Marketing. Journal of Consumer Research 39: 157-173.

Medicine Patent Pool. 2015. About the MPP. http://www.medicinespatentpool.org/about/. Accessed 18 Feb 2015.

Miller, C.L., et al. 2011. Food Insecurity and Sexual Risk in an HIV Endemic Community in Uganda. AIDS and Behavior 15(7): 1512-1519.

National Institute of Allergy and Infectious Diseases (NIAID). 2015. Ebola Vaccine Trial Opens in Liberia—Study Led by Liberia-NIH Partnership Will Test Two Experimental Vaccines. http:// www.niaid.nih.gov/news/newsreleases/2015/Pages/PREVAIL.aspx. Accessed 1 Mar 2015.

Nunn, A., E. Fonseca, and S. Gruskin. 2009. Changing Global Essential Medicines Norms to Improve Access to AIDS Treatment: Lessons from Brazil. Global Public Health 4(2): 131-149.

Onishi, N. 2015, April 11. Empty Ebola Clinics in Liberia are Seen as Misstep in U.S. Relief Effort. New York Times. http://www.nytimes.com/2015/04/12/world/africa/idle-ebola-clinics- in-liberia-are-seen-as-misstep-in-us-relief-effort.html. Accessed 16 Apr 2015.

Pogge, T.W. 2005. World Poverty and Human Rights. Ethics International Affairs 19: 4.

Pollack, A. 2014, August 8. Ebola Drug Could Save a Few Lives. But Whose? New York Times. http://www.nytimes.com/2014/08/09/health/in-ebola-outbreak-who-should-get-experimental- drug.html. Accessed 4 Mar 2015.

Population Reference Bureau. 2014 Africa—Sub-Saharan. http://www.prb.org/DataFinder/ Geography/Data.aspx?loc=247. Accessed 18 Feb 2015.

Reich, M. 1993. Essential Drugs: Economics and Politics in International Health. In The Pharmaceutical Corporate Presence in Developing Countries, ed. Travis and Williams, 83-108. Notre Dame, Indiana: University of Notre Dame Press.

Resnik, D.B. 2001. Developing Drugs for the Developing World: An Economic, Legal, Moral, and Political Dilemma. Developing World Bioethics 1(1): 11-32.

Rettner, R. 2014. Could Ebola Really Be The ‘Next AIDS’? Lifescience. http://www.livescience. com/48232-ebola-aids-comparison.html. Accessed 23 Feb 2015.

Rid, A., and E.J. Emanuel. 2014. Ethical Considerations of Experimental Interventions in the Ebola Outbreak. Lancet 384(9957): 1896-1899.

Sayburn, A. 2014. WHO Gives Go Ahead for Experimental Treatments to be Used in Ebola Outbreak. British Medical Journal 349: g5161.

Scanlon, T.M. 1998. What We Owe to Each Other. Cambridge, MA: Belknap Press of Harvard University Press.

Schneider, H., et al. 2006. Health Systems and Access to Antiretroviral Drugs for HIV in Southern Africa: Service Delivery and Human Resource Challenges. Reproductive Health Matters 14(27): 12-23.

Schuklenk, U., and R.E. Ashcroft. 2002. Affordable Access to Essential Medication in Developing Countries: Conflicts Between Ethical and Economic Imperatives. The Journal of Medicine and Philosophy 27(2): 179-195.

Setayesh, H., et al. 2014. HIV and AIDS in the Middle East and North Africa. Washington, DC: Population Reference Bureau.

Singer, P. 1972. Famine, Affluence, and Morality. Philosophy and Public Affairs 1: 229-243.

Spinello, R.A. 1992. Ethics, Pricing and the Pharmaceutical Industry. Journal of Business Ethics 11(8): 617-626.

Streckx, S. 2004. Patents and Access to Drugs in Developing Countries: An Ethical Analysis. Developing World Bioethics 4(1): 1471-8847.

The Global Fund to Fight AIDS, Tuberculosis and Malaria. n.d. http://www.theglobalfund.org/en/. Accessed 18 Feb 2015.

The World Bank. 2014. Worldwide Governance Reports: Country Data Reports. http://info.world- bank.org/governance/wgi/index.aspx#countryReports. Accessed 27 Feb 2015.

--. 2015a. Military expenditure (% of GDP). http://data.worldbank.org/indicator/MS.MIL.

XPND.GD.ZS/countries. Accessed 27 Feb 2015.

--. 2015b Health expenditure, total (% of GDP). http://data.worldbank.org/indicator/SH.

XPD.TOTL.ZS/countries. Accessed 27 Feb 2015.

Thigpen, M.C., et al. 2012. Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana. The New England Journal of Medicine 367: 423-434.

Tsai, A.C., D.R. Bangsberg, and S.D. Weiser. 2013. Harnessing Poverty Alleviation to Reduce the Stigma of HIV in Sub-Saharan Africa. PLoS Medicine 10(11): e1001557.

UNAIDS. 2010. Removing Bottle-necks for Universal Access in Central African Republic. http:// www.unaids.org/en/resources/presscentre/featurestories/2010/february/20100208car. Accessed 23 Feb 2015.

--. 2014a. Fact sheet. http://www.unaids.org/en/resources/campaigns/2014/2014gapreport/

factsheet. Accessed 18 Feb 2015.

--. 2014b. The Gap Report. http://www.unaids.org/sites/default/files/media_asset/UNAIDS_

Gap_report_en.pdf. Accessed 18 Feb 2015.

--. 2014c. UNAIDS Report Shows that 19 Million of the 35 Million People Living with HIV

Today Do Not Know that They Have the Virus. http://www.unaids.org/en/resources/presscentre/ pressreleaseandstatementarchive/2014/july/20140716prgapreport. Accessed 18 Feb 2015.

--. 2014d. Raising Awareness of HIV Testing and Counselling in South Sudan. http://www.

unaids.org/en/resources/presscentre/featurestories/2014/june/20140623southsudantesting. Accessed 23 Feb 2015.

United Nations. Declaration of Universal Human Rights. http://www.un.org/Overview/rights.html. Accessed 18 Feb 2015.

United Nations Development Programme. 2013. Human Development Report 2013. The Rise of the South: Human Progress in a Diverse World. http://hdr.undp.org/sites/default/files/ reports/14/hdr2013_en_complete.pdf. Accessed 18 Feb 2015.

Wettstein, F. 2012. CSR and the Debate on Business and Human Rights: Bridging the Great Divide. Business Ethics Quarterly 22(4): 739-770.

World Health Organization. 2006. Constitution of the World Health Organization. http://www. who.int/governance/eb/who_constitution_en.pdf. Accessed 18 Feb 2015.

--. 2011. Global Health Sector Strategy on HIV/AIDS 2011-2015. http://whqlibdoc.who.int/

publications/2011/9789241501651_eng.pdf?ua=1. Accessed 23 Feb 2015.

--. 2014. Fact Sheet No. 104 Tuberculosis. http://www.who.int/mediacentre/factsheets/fs104/

en/. Accessed 18 Feb 2015.

--. 2015a Essential Medicines and Health Products. http://www.who.int/medicines/services/

essmedicines_def/en/. Accessed 18 Feb 2015.

--. 2015b Health Workforce: Density of Physicians (Total Number per 1000 Population):

Latest available year. http://gamapserver.who.int/gho/interactive_charts/health_workforce/ PhysiciansDensity_Total/tablet/atlas.html. Accessed 27 Feb 2015.

--. 2015c. Ebola Situation Report-8 April 2015. http://apps.who.int/ebola/current-situation/

ebola-situation-report-8-april-2015. Accessed 16 April 2015.

Youde, J. 2005. The Development of a Counter-Epistemic Community: AIDS, South Africa, and International Regimes. International Relations 19: 421-439.

 
Source
Found a mistake? Please highlight the word and press Shift + Enter  
< Prev   CONTENTS   Next >
 
Subjects
Accounting
Business & Finance
Communication
Computer Science
Economics
Education
Engineering
Environment
Geography
Health
History
Language & Literature
Law
Management
Marketing
Mathematics
Political science
Philosophy
Psychology
Religion
Sociology
Travel